COO: Rega marang dodolan The Cooper Companies, Inc.
Material innovations and physician support create a robust defensive barrier for The Cooper Companies (COO). The cost-to-sales ratio visualizes this resilience, with 2.80 serving as the current metric level. Stability is driven by leadership in the lenses and women's health segments. An oligopolistic status and strict prescription requirements allow the company to confidently exercise pricing power.
Rincian analitis perusahaan CooperVision (COO)
- rega pasar lan target rega analis:
- informasi kapitalisasi pasar:
- data nilai buku modal saham:
- statistik kawajiban utang lan likuiditas:
Rasio Total Utang marang Ekuitas The Cooper Companies|COO - Utang jangka dawa marang modal|Utang jangka cendhak marang modal CooperSurgical|COO - Utang perusahaan|Rasio utang marang kapitalisasi buku CooperVision|COO - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan CooperCompanies|Likuiditas darurat coopercos.com
- indikator pendapatan resik lan kelipatan nilai:
COO - Bathi resik perusahaan|Proyeksi bathi resik The Cooper Companies|COO - Koefisien rega marang bathi|Pangali Forward P/E The Cooper Companies, Inc.|COO - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan CooperVision|COO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan CooperCompanies|COO - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi resik saben saham taun-ka-taun sajrone 12 wulan pungkasan coopercos.com|COO - Wutah bathi ing taun lumaku|Prakiraan wutah bathi resik saben saham ing taun ngarep The Cooper Companies
- rincian pendapatan lan dodolan emiten:
Analisis fundamental perusahaan:coopercos.com COO
To minimize fundamental risks, investors should utilize the market capitalization-to-annual revenue ratio, which determines the cost of one dollar of sales and identifies asset overvaluation. For The Cooper Companies (COO), which invests in a staff of unique specialists and innovation, the P/S ratio chart allows for an assessment of the extent to which the market is willing to award a premium for the high cost of medical equipment development relative to current sales volumes.
Karo sapa The Cooper Companies saingan
Kapitalisasi marang pendapatan bostonscientific.com BSX|Multiplikator P/S EW (Edwards Lifesciences Corporation)|ResMed Inc (RMD) - Rega marang dodolan|OmniPod - Multiplikator P/S|ZBH (Zimmer Biomet Holdings) - Rasio kapitalisasi marang pendapatan|ALGN: Multiplikator P/S|GMED - Koefisien rega marang pendapatan|TMDX (TransMedics Group, Inc.) - Multiplikator P/S|Kapitalisasi marang pendapatan Alphatec Holdings (ATEC)|Multiplikator P/S AORT|Multiplikator P/S Enovis Inc. (ENOV)|Rasio rega marang pendapatan Integra LifeSciences IART|establishmentlabs.com - Rasio rega marang pendapatan|BBNX: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IRMD (IRADIMED Corp)|EMBC: Multiplikator P/S|Rega marang dodolan Tandem Corp (TNDM)|Rasio rega marang pendapatan AxoGen, Inc.|SIBN - Multiplikator rega marang pendapatan|Kapitalisasi marang pendapatan OFIX (Orthofix)|Multiplikator P/S Bioventus Inc (BVS)|Multiplikator P/S KIDS (OrthoPediatrics)|Koefisien rega marang pendapatan Treace Corp (TMCI)|SRTA - Rasio rega marang pendapatan|Rasio rega marang dodolan CARL|RxSight (RXST) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan ClearPoint Neuro|STXS (Stereotaxis Corp) - Multiplikator P/S|Rega marang dodolan Neuronetics, Inc STIM|Rasio rega marang pendapatan Sight Sciences, Inc. (SGHT)|orchestrabiomed.com - Rasio kapitalisasi marang pendapatan|Anika Therapeutics, Inc. - Kapitalisasi marang pendapatan|Kapitalisasi marang volume dodolan NSPR (InspireMD Inc)|ZJYL: Kapitalisasi marang pendapatan|Vivani Medical, Inc. - Kapitalisasi marang volume dodolan|XTNT: Multiplikator P/S|n1mtc.com - Rasio kapitalisasi pasar marang pendapatan|MODD (Modular Medical Inc) - Multiplikator P/S|Rega marang dodolan Myomo Inc. MYO|Kapitalisasi marang pendapatan COCH (Envoy Medical, Inc)|VVOS (Vivos Therapeutics Inc) - Rasio kapitalisasi pasar marang pendapatan|Multiplikator P/S NVNO (enVVeno Medical)|SINT - Kapitalisasi marang pendapatan|TNON - Rasio rega marang pendapatan|Rega marang dodolan ReWalk Robotics|autonomix.com (AMIX) - Rasio rega marang pendapatan|Rega marang dodolan INVO Fertility Corp (IVF)|Rasio rega marang pendapatan Bone Biologics|axonics.com - Rasio rega marang dodolan|Multiplikator P/S BIOL|DYNT - Rega marang dodolan|Rasio rega marang pendapatan Paragon 28 FNA|Rasio kapitalisasi pasar marang pendapatan INVO
